Impact of extending the lookback period on the estimated prevalence of inflammatory bowel disease in administrative claims data

被引：0
|
作者：
Dawwas, Ghadeer K. [1 ]
Haynes, Kevin [2 ]
Parlett, Lauren [3 ]
Brensinger, Colleen M. [1 ]
Chen, Xiaoxue [2 ]
Wu, Qufei [1 ]
Kappelman, Michael D. [4 ]
Lewis, James D. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] HealthCore Inc, Wilmington, DE USA
[3] HealthCore Inc, Alexandria, VA USA
[4] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
5099
引用
收藏
页码：414 / 415
页数：2
相关论文
共 50 条
  • [41] Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior
    Banerjee, Rupa
    Pal, Partha
    Hutfless, Susan
    Ganesh, B. Girish
    Reddy, D. Nageshwar
    INTESTINAL RESEARCH, 2019, 17 (04) : 486 - 495
  • [42] FAMILIAL AGGREGATION OF INFLAMMATORY BOWEL DISEASE IN INDIA: PREVALENCE, RISKS AND IMPACT ON DISEASE BEHAVIOUR
    Pal, Partha
    Banerjee, Rupa
    GUT, 2018, 67 : A87 - A88
  • [43] Estimates of Disease Course in Inflammatory Bowel Disease Using Administrative Data: A Population-level Study
    Melesse, Dessalegn Y.
    Lix, Lisa M.
    Nugent, Zoann
    Targownik, Laura E.
    Singh, Harminder
    Blanchard, James F.
    Bernstein, Charles N.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (05): : 562 - 570
  • [44] Racial and Ethnic Differences in Diagnosed Prevalence, Specialist Visits, and Treatment Utilization of Inflammatory Bowel Disease: Retrospective Analysis of US Claims Data
    Sharma, Dolly
    Xuan, Si
    Sanchez-Gonzalez, Yuri
    Griffith, Jenny
    Malter, Lisa
    Afzali, Anita
    Rubin, David T.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1813 - S1814
  • [45] Prevalence, Causes and Impact of Abnormal Liver Biochemistries in Patients With Inflammatory Bowel Disease
    Bonnivard, Sophie
    Cadiot, Guillaume
    Berlot, Alexandra Heurgue
    Brixi, Hedia
    GASTROENTEROLOGY, 2015, 148 (04) : S455 - S455
  • [46] Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases
    Dawwas, Ghadeer K.
    Weiss, Alexandra
    Constant, Brad D.
    Parlett, Lauren E.
    Haynes, Kevin
    Yang, Jeff Yufeng
    Brensinger, Colleen
    Wu, Qufei
    Pate, Virginia
    Funk, Michele Jonsson
    Schaubel, Douglas E.
    Hurtado-Lorenzo, Andres
    Kappelman, Michael David
    Lewis, James D.
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (12) : 1993 - 1996
  • [47] Prevalence, risk factors, and impact of frailty among outpatients with inflammatory bowel disease
    Nasr, M.
    Segboer, H.
    Mitrev, N.
    Corte, C.
    Liu, K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 : 123 - 123
  • [48] ECONOMIC IMPACT OF PERIANAL FISTULIZING CROHN'S DISEASE IN US ADMINISTRATIVE CLAIMS DATA.
    Chen, G.
    Shrestha, S.
    Wang, L.
    Cazzetta, S.
    Khan, Q. Rana
    Schwartz, D.
    Null, K.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E447 - E447
  • [49] Sickle Cell Disease Prevalence in a Large US Administrative Claims Database
    Grace, Elsie L.
    Asiimwe, Alex
    Jones, Meghan
    Michael, James A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 399 - 399
  • [50] Using Administrative Healthcare Data to Study the Treatment of Inflammatory Bowel Disease in the Region of Stockholm, Sweden
    Cars, Thomas
    Lordal, Mikael
    Wettermark, Bjorn
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 137 - 137
12345